Claim Missing Document
Check
Articles

Found 2 Documents
Search

Embolisasi Trans Arterial Pra Operasi pada Metastatic Bone Disease dari Renal Cell Carcinoma Achmad; Rizqi, Putri; Setyawan, Agung; Aslam, Achmad
Jurnal Klinik dan Riset Kesehatan Vol 1 No 3 (2022): Edisi Juni
Publisher : RSUD Dr. Saiful Anwar Province of East Java

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11594/jk-risk.01.3.7

Abstract

Metastasis has been literally defined as the spread of cancer from the main body part when the cancer starts to induce other parts of the body. Approximately, one third of patients with advanced renal cell carcinoma (RCC) have presented bone metastases which are often osteolytic causing substantial morbidity, such as: pain pathological fractures, spinal cord compression and hypercalcemia. Additionally, the presence of bone metastases in RCC is also associated with a poor prognosis. This paper reports a case presentation regarding embolization in a case of a 25-year-old female patient with a pathological diagnosis of a pathological fracture at the L1 level dt MBD Process Renal Cell Carcinoma prior to spinal stabilization surgery. Embolization hence plays an important role in treating hypervascular bone metastases, providing effective means of treating hemorrhagic conditions by minimizing the bleeding supply to tumor masses. In sum, embolization could be performed either as a definitive treatment or as an adjunct to subsequent surgical management.
Successful Embolization in Recurrent Hemoptysis Caused by Pulmonary Aspergilloma: A Case Report: Successful Embolization in Recurrent Hemoptysis Caused by Pulmonary Aspergilloma Yaman, Muli; Sugiri, Jane; Putra, Ngakan; Santosaningsih, Dewi; Aslam, Achmad
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.4

Abstract

Background: Aspergilloma is a fungal infection that can cause recurrent hemoptysis. One of the treatment modalities is embolization, which has a success rate of 85% to 100%, although the recurrence rate may reach 10% to 33%. Case Illustration: A 29-year-old female came to the emergency ward with recurrent hemoptysis. She had a history of tuberculosis with completed treatment 7 years ago. Chest radiography showed left lung tuberculosis with emphysematous lung. Chest CT with contrast revealed an air-crescent sign, and culture from bronchoalveolar lavage (BAL) showed Aspergillus spp. Then, she was diagnosed with pulmonary aspergilloma. Embolization was performed in the left internal mammary artery, and the blushing was decreased by 80%. However, the hemoptysis was still recurrent; a second embolization was performed in the left supreme intercostal artery, costocervical trunk artery, and bronchial artery, resulting in no blushing. The patient had no further episodes of hemoptysis, and her antifungal therapy was changed from fluconazole to voriconazole. Discussion: Recurrent hemoptysis can be caused by pulmonary aspergilloma. Embolization is usually done to reduce bleeding before surgery. The patient had performed embolization 2 times with no further episodes of hemoptysis. Surgical resection as a definitive treatment was recommended in this case, but the patient refused. Therefore, the patient’s management was optimized using voriconazole and embolization for the hemoptysis. Conclusion: Management of recurrent hemoptysis in patients with aspergilloma may include embolization and antifungal treatment which give improved clinical outcomes. Keywords: recurrent hemoptysis, embolization, aspergilloma, tuberculosis